INVVY News and Press, Indivior PLC ADR From 02/14/19

The following slide deck was published by INDIVIOR PLC ADR in conjunction with their 2018 Q4 earnings Read more ...

The U.S. Court of Appeals for the Federal Circuit has denied a motion from Indivior ( OTCPK:INVVY -5.2% ) for a rehearing to reinstate the preliminary injunction against Dr. Reddy's Laboratories ( RDY +0.7% ) stopping it from marketing a generic version of opioid dependence treatm...

WARREN, N.J. , Jan. 25, 2019 /PRNewswire/ -- Aquestive Therapeutics, Inc. (Nasdaq: AQST), a specialty pharmaceutical company, focused on developing and commercializing differentiated products to solve therapeutic problems, today announced that the U.S. District Court for the District...

A study just published in JAMA Open Network conducted by researchers at Brown University found a strong link between the amount spent on marketing by opioid manufacturers and the number of prescriptions written by doctors, leading to a rise in opioid overdose deaths. More news on: Endo...

Massachusetts Attorney General Maura Healey has filed an amended lawsuit against privately held Purdue Pharma aimed at holding members of the controlling Sackler family personally responsible for its role in the opioid crisis. More news on: Endo International plc, Mallinckrodt PLC, INDIV...

CUPERTINO, Calif. , Jan. 7, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) has refined and focused its clinical development strategy for DUR-928, the lead product candidate in its Epigenetic Regulator Program, to prioritize indications with unmet medical needs where we expect...

Well, it had to happen eventually, hadn't it? After a barnstorming 43% return in 2017, the No-Admin-Portfolio-System ((NAPS)) hit a wall in 2018. My musings on the benefits of ignorance last January led to nearly 100,000 reads over the year but, if private investor sentiment is anything to...

Aquestive Therapeutics (NASDAQ: AQST ) is reporting positive developments across its business. More news on: Aquestive Therapeutics, INDIVIOR PLC ADR, Healthcare stocks news, Read more ...

SLOUGH, England and RICHMOND, Va. , Dec. 20, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication of the study design and participant characteristics of the RECOVER (Remission from Chronic Opioid Use-Studying Environmental and Socio-Economic Factors o...

WARREN, N.J. , Dec. 20, 2018 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company pharmaceutical company focused on identifying, developing, and commercializing differentiated products to solve therapeutic problems, is reporting positive dev...